Videos / An update on semaglutide for CKD in the presence of T2D
In this Product Explainer, Endocrinologist Prof Richard MacIsaac provides an update on the chronic kidney disease (CKD) indication for semaglutide, explains the PBS criteria and how healthcare professionals can initiate this GLP-1 RA.

Eczema Practical Updates for General Practice

Cow’s Milk Allergy in Infants and Children

RSV Vaccine on the NIP – What You Need to Know

Vitiligo – Early Detection and Early Treatment

expert
Endocrinologist, Director, St Vincent’s Hospital Melbourne; Professor, University of Melbourne